Raymond T. Chung, MD

Novel hepatitis B virus RNA and HBV core-related antigen blood assays revealed continued disease activity despite apparently suppressed virus replication among patients dosed with antiviral therapy for HBV and HIV coinfection.

Direct-acting antiviral therapies have had far-reaching consequences in the treatment of hepatitis C, and that has extended to patients awaiting potentially life-saving liver transplant.